icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
Denver, Colorado
March 3-6 2024
Back grey_arrow_rt.gif
 
 
 
Effects of Semaglutide on Muscle Structure and Function in the SLIM Liver Study
 
 
  CROI 2024 March 3-6 Denver
 
Grace L. Ditzenberger, Jordan E. Lake, Douglas W. Kitch, Amy Kantor, Raja Muthupillai, Pablo Belaunzaran-Zamudio, Todd T. Brown, Kathleen Corey, Alan Landay, Anchalee Avihingsanon, Fred R. Sattler, Kristine M. Erlandson
 
The purpose of this analysis was to examine changes in muscle quality, quantity, and function among people with HIV (PWH) treated with semaglutide for metabolic-associated steatotic liver disease (MASLD), aka Fatty Liver Disease, NAFLD, NASH.

0312241

0312242

0312243

0312244

0312245

0312246

0312247

0312248

0312249